JOURNAL OF MOLECULAR GRAPHICS & MODELLING-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1093703, encodeId=43c01093e0399, content=选刊时选择几个比较合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093704, encodeId=56921093e0453, content=如何评估自身文章的IF，或者说如何更好地定位自己的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835765, encodeId=7da0835e65ea, content=一审很快，去年12月8号投的，23号接到一审，一个审稿人同意接收，另外一个审稿人大修。期间经历一些波折，编辑没有附上大修的审稿人的审稿意见。发邮件询问时赶上圣诞节，一直等到今年的1月9日才回复。1月19日投回之后，二审等了4周，2月19日意见回来，大修的审稿人同意接收，但编辑又找了第三个审稿人，给了小修。编辑在信中说修回去会直接接收不会再外审。用了2天修回，没想到又送了外审，等了两周今天终于接收了。其实文章本身没怎么改，第二个审稿人的大修难度也不大，审稿也比较快，但在编辑那算起来多耽误了一个多月的时间。不管怎样，文章接收了，感谢编辑和审稿人的肯定。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdb65414148, createdName=ms9921507639737342, createdTime=Mon Mar 06 23:45:32 CST 2017, time=2017-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=830407, encodeId=948283040efb, content=审稿速度:1.0 经验分享：从投稿开始到接受总共26天，其中还包括投稿后返修的1个星期，审稿速度很快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04015414150, createdName=ms9574107592528786, createdTime=Sat Apr 25 08:27:21 CST 2015, time=2015-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=829891, encodeId=dad78298913f, content=审稿速度:2.0 经验分享：只能好历经接近一年终于接收了，中间出现了n个审稿人， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a645414058, createdName=ms2534931155419844, createdTime=Thu Oct 09 02:17:07 CST 2014, time=2014-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=824408, encodeId=5332824408d4, content=计算机模拟方面的期刊，药效团、分子对接、分子动力学模拟方面的文章都收，似乎计算化学类的都可以试试。 本人在这个期刊的投稿经历很痛苦。 第一次投稿，1个月后告知拒稿，理由我很信服，因为是做的同源建模，蛋白的模板以不是最新的同源性高的模板，而且审稿人还提出了其他的一些问题。看到了不足，继续改。想再投一遍试试。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Mon Mar 11 16:59:00 CST 2013, time=2013-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=823645, encodeId=fc7e82364594, content=但愿有好消息呀，已经大修一次了，第二次有个审稿人要拒掉，不知道是凶是吉。 有结果会写下来。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ac05413990, createdName=ms1582630781068122, createdTime=Sun Jan 20 00:05:00 CST 2013, time=2013-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=822980, encodeId=7f84822980b6, content=已经投稿，希望有好的结果~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69165414090, createdName=ms5297671486900813, createdTime=Tue Dec 11 11:37:00 CST 2012, time=2012-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485956, encodeId=36e348595648, content=郁闷！4个月个还处在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Dec 19 21:37:00 CST 2011, time=2011-12-19, status=1, ipAttribution=)]

2021-12-28 桑晒麦拉

选刊时选择几个比较合适？

75 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1093703, encodeId=43c01093e0399, content=选刊时选择几个比较合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093704, encodeId=56921093e0453, content=如何评估自身文章的IF，或者说如何更好地定位自己的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835765, encodeId=7da0835e65ea, content=一审很快，去年12月8号投的，23号接到一审，一个审稿人同意接收，另外一个审稿人大修。期间经历一些波折，编辑没有附上大修的审稿人的审稿意见。发邮件询问时赶上圣诞节，一直等到今年的1月9日才回复。1月19日投回之后，二审等了4周，2月19日意见回来，大修的审稿人同意接收，但编辑又找了第三个审稿人，给了小修。编辑在信中说修回去会直接接收不会再外审。用了2天修回，没想到又送了外审，等了两周今天终于接收了。其实文章本身没怎么改，第二个审稿人的大修难度也不大，审稿也比较快，但在编辑那算起来多耽误了一个多月的时间。不管怎样，文章接收了，感谢编辑和审稿人的肯定。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdb65414148, createdName=ms9921507639737342, createdTime=Mon Mar 06 23:45:32 CST 2017, time=2017-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=830407, encodeId=948283040efb, content=审稿速度:1.0 经验分享：从投稿开始到接受总共26天，其中还包括投稿后返修的1个星期，审稿速度很快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04015414150, createdName=ms9574107592528786, createdTime=Sat Apr 25 08:27:21 CST 2015, time=2015-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=829891, encodeId=dad78298913f, content=审稿速度:2.0 经验分享：只能好历经接近一年终于接收了，中间出现了n个审稿人， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a645414058, createdName=ms2534931155419844, createdTime=Thu Oct 09 02:17:07 CST 2014, time=2014-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=824408, encodeId=5332824408d4, content=计算机模拟方面的期刊，药效团、分子对接、分子动力学模拟方面的文章都收，似乎计算化学类的都可以试试。 本人在这个期刊的投稿经历很痛苦。 第一次投稿，1个月后告知拒稿，理由我很信服，因为是做的同源建模，蛋白的模板以不是最新的同源性高的模板，而且审稿人还提出了其他的一些问题。看到了不足，继续改。想再投一遍试试。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Mon Mar 11 16:59:00 CST 2013, time=2013-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=823645, encodeId=fc7e82364594, content=但愿有好消息呀，已经大修一次了，第二次有个审稿人要拒掉，不知道是凶是吉。 有结果会写下来。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ac05413990, createdName=ms1582630781068122, createdTime=Sun Jan 20 00:05:00 CST 2013, time=2013-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=822980, encodeId=7f84822980b6, content=已经投稿，希望有好的结果~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69165414090, createdName=ms5297671486900813, createdTime=Tue Dec 11 11:37:00 CST 2012, time=2012-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485956, encodeId=36e348595648, content=郁闷！4个月个还处在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Dec 19 21:37:00 CST 2011, time=2011-12-19, status=1, ipAttribution=)]

2021-12-28 MS68862005

如何评估自身文章的IF，或者说如何更好地定位自己的文章？

72 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1093703, encodeId=43c01093e0399, content=选刊时选择几个比较合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093704, encodeId=56921093e0453, content=如何评估自身文章的IF，或者说如何更好地定位自己的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835765, encodeId=7da0835e65ea, content=一审很快，去年12月8号投的，23号接到一审，一个审稿人同意接收，另外一个审稿人大修。期间经历一些波折，编辑没有附上大修的审稿人的审稿意见。发邮件询问时赶上圣诞节，一直等到今年的1月9日才回复。1月19日投回之后，二审等了4周，2月19日意见回来，大修的审稿人同意接收，但编辑又找了第三个审稿人，给了小修。编辑在信中说修回去会直接接收不会再外审。用了2天修回，没想到又送了外审，等了两周今天终于接收了。其实文章本身没怎么改，第二个审稿人的大修难度也不大，审稿也比较快，但在编辑那算起来多耽误了一个多月的时间。不管怎样，文章接收了，感谢编辑和审稿人的肯定。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdb65414148, createdName=ms9921507639737342, createdTime=Mon Mar 06 23:45:32 CST 2017, time=2017-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=830407, encodeId=948283040efb, content=审稿速度:1.0 经验分享：从投稿开始到接受总共26天，其中还包括投稿后返修的1个星期，审稿速度很快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04015414150, createdName=ms9574107592528786, createdTime=Sat Apr 25 08:27:21 CST 2015, time=2015-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=829891, encodeId=dad78298913f, content=审稿速度:2.0 经验分享：只能好历经接近一年终于接收了，中间出现了n个审稿人， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a645414058, createdName=ms2534931155419844, createdTime=Thu Oct 09 02:17:07 CST 2014, time=2014-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=824408, encodeId=5332824408d4, content=计算机模拟方面的期刊，药效团、分子对接、分子动力学模拟方面的文章都收，似乎计算化学类的都可以试试。 本人在这个期刊的投稿经历很痛苦。 第一次投稿，1个月后告知拒稿，理由我很信服，因为是做的同源建模，蛋白的模板以不是最新的同源性高的模板，而且审稿人还提出了其他的一些问题。看到了不足，继续改。想再投一遍试试。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Mon Mar 11 16:59:00 CST 2013, time=2013-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=823645, encodeId=fc7e82364594, content=但愿有好消息呀，已经大修一次了，第二次有个审稿人要拒掉，不知道是凶是吉。 有结果会写下来。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ac05413990, createdName=ms1582630781068122, createdTime=Sun Jan 20 00:05:00 CST 2013, time=2013-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=822980, encodeId=7f84822980b6, content=已经投稿，希望有好的结果~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69165414090, createdName=ms5297671486900813, createdTime=Tue Dec 11 11:37:00 CST 2012, time=2012-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485956, encodeId=36e348595648, content=郁闷！4个月个还处在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Dec 19 21:37:00 CST 2011, time=2011-12-19, status=1, ipAttribution=)]

2017-03-06 ms9921507639737342

一审很快，去年12月8号投的，23号接到一审，一个审稿人同意接收，另外一个审稿人大修。期间经历一些波折，编辑没有附上大修的审稿人的审稿意见。发邮件询问时赶上圣诞节，一直等到今年的1月9日才回复。1月19日投回之后，二审等了4周，2月19日意见回来，大修的审稿人同意接收，但编辑又找了第三个审稿人，给了小修。编辑在信中说修回去会直接接收不会再外审。用了2天修回，没想到又送了外审，等了两周今天终于接收了。其实文章本身没怎么改，第二个审稿人的大修难度也不大，审稿也比较快，但在编辑那算起来多耽误了一个多月的时间。不管怎样，文章接收了，感谢编辑和审稿人的肯定。

103 0

[GetPortalCommentsPageByObjectIdResponse(id=1093703, encodeId=43c01093e0399, content=选刊时选择几个比较合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093704, encodeId=56921093e0453, content=如何评估自身文章的IF，或者说如何更好地定位自己的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835765, encodeId=7da0835e65ea, content=一审很快，去年12月8号投的，23号接到一审，一个审稿人同意接收，另外一个审稿人大修。期间经历一些波折，编辑没有附上大修的审稿人的审稿意见。发邮件询问时赶上圣诞节，一直等到今年的1月9日才回复。1月19日投回之后，二审等了4周，2月19日意见回来，大修的审稿人同意接收，但编辑又找了第三个审稿人，给了小修。编辑在信中说修回去会直接接收不会再外审。用了2天修回，没想到又送了外审，等了两周今天终于接收了。其实文章本身没怎么改，第二个审稿人的大修难度也不大，审稿也比较快，但在编辑那算起来多耽误了一个多月的时间。不管怎样，文章接收了，感谢编辑和审稿人的肯定。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdb65414148, createdName=ms9921507639737342, createdTime=Mon Mar 06 23:45:32 CST 2017, time=2017-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=830407, encodeId=948283040efb, content=审稿速度:1.0 经验分享：从投稿开始到接受总共26天，其中还包括投稿后返修的1个星期，审稿速度很快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04015414150, createdName=ms9574107592528786, createdTime=Sat Apr 25 08:27:21 CST 2015, time=2015-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=829891, encodeId=dad78298913f, content=审稿速度:2.0 经验分享：只能好历经接近一年终于接收了，中间出现了n个审稿人， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a645414058, createdName=ms2534931155419844, createdTime=Thu Oct 09 02:17:07 CST 2014, time=2014-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=824408, encodeId=5332824408d4, content=计算机模拟方面的期刊，药效团、分子对接、分子动力学模拟方面的文章都收，似乎计算化学类的都可以试试。 本人在这个期刊的投稿经历很痛苦。 第一次投稿，1个月后告知拒稿，理由我很信服，因为是做的同源建模，蛋白的模板以不是最新的同源性高的模板，而且审稿人还提出了其他的一些问题。看到了不足，继续改。想再投一遍试试。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Mon Mar 11 16:59:00 CST 2013, time=2013-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=823645, encodeId=fc7e82364594, content=但愿有好消息呀，已经大修一次了，第二次有个审稿人要拒掉，不知道是凶是吉。 有结果会写下来。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ac05413990, createdName=ms1582630781068122, createdTime=Sun Jan 20 00:05:00 CST 2013, time=2013-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=822980, encodeId=7f84822980b6, content=已经投稿，希望有好的结果~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69165414090, createdName=ms5297671486900813, createdTime=Tue Dec 11 11:37:00 CST 2012, time=2012-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485956, encodeId=36e348595648, content=郁闷！4个月个还处在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Dec 19 21:37:00 CST 2011, time=2011-12-19, status=1, ipAttribution=)]

2015-04-25 ms9574107592528786

审稿速度:1.0
经验分享：从投稿开始到接受总共26天，其中还包括投稿后返修的1个星期，审稿速度很快

114 0

[GetPortalCommentsPageByObjectIdResponse(id=1093703, encodeId=43c01093e0399, content=选刊时选择几个比较合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093704, encodeId=56921093e0453, content=如何评估自身文章的IF，或者说如何更好地定位自己的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835765, encodeId=7da0835e65ea, content=一审很快，去年12月8号投的，23号接到一审，一个审稿人同意接收，另外一个审稿人大修。期间经历一些波折，编辑没有附上大修的审稿人的审稿意见。发邮件询问时赶上圣诞节，一直等到今年的1月9日才回复。1月19日投回之后，二审等了4周，2月19日意见回来，大修的审稿人同意接收，但编辑又找了第三个审稿人，给了小修。编辑在信中说修回去会直接接收不会再外审。用了2天修回，没想到又送了外审，等了两周今天终于接收了。其实文章本身没怎么改，第二个审稿人的大修难度也不大，审稿也比较快，但在编辑那算起来多耽误了一个多月的时间。不管怎样，文章接收了，感谢编辑和审稿人的肯定。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdb65414148, createdName=ms9921507639737342, createdTime=Mon Mar 06 23:45:32 CST 2017, time=2017-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=830407, encodeId=948283040efb, content=审稿速度:1.0 经验分享：从投稿开始到接受总共26天，其中还包括投稿后返修的1个星期，审稿速度很快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04015414150, createdName=ms9574107592528786, createdTime=Sat Apr 25 08:27:21 CST 2015, time=2015-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=829891, encodeId=dad78298913f, content=审稿速度:2.0 经验分享：只能好历经接近一年终于接收了，中间出现了n个审稿人， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a645414058, createdName=ms2534931155419844, createdTime=Thu Oct 09 02:17:07 CST 2014, time=2014-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=824408, encodeId=5332824408d4, content=计算机模拟方面的期刊，药效团、分子对接、分子动力学模拟方面的文章都收，似乎计算化学类的都可以试试。 本人在这个期刊的投稿经历很痛苦。 第一次投稿，1个月后告知拒稿，理由我很信服，因为是做的同源建模，蛋白的模板以不是最新的同源性高的模板，而且审稿人还提出了其他的一些问题。看到了不足，继续改。想再投一遍试试。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Mon Mar 11 16:59:00 CST 2013, time=2013-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=823645, encodeId=fc7e82364594, content=但愿有好消息呀，已经大修一次了，第二次有个审稿人要拒掉，不知道是凶是吉。 有结果会写下来。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ac05413990, createdName=ms1582630781068122, createdTime=Sun Jan 20 00:05:00 CST 2013, time=2013-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=822980, encodeId=7f84822980b6, content=已经投稿，希望有好的结果~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69165414090, createdName=ms5297671486900813, createdTime=Tue Dec 11 11:37:00 CST 2012, time=2012-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485956, encodeId=36e348595648, content=郁闷！4个月个还处在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Dec 19 21:37:00 CST 2011, time=2011-12-19, status=1, ipAttribution=)]

2014-10-09 ms2534931155419844

审稿速度:2.0
经验分享：只能好历经接近一年终于接收了，中间出现了n个审稿人，

102 0

[GetPortalCommentsPageByObjectIdResponse(id=1093703, encodeId=43c01093e0399, content=选刊时选择几个比较合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093704, encodeId=56921093e0453, content=如何评估自身文章的IF，或者说如何更好地定位自己的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835765, encodeId=7da0835e65ea, content=一审很快，去年12月8号投的，23号接到一审，一个审稿人同意接收，另外一个审稿人大修。期间经历一些波折，编辑没有附上大修的审稿人的审稿意见。发邮件询问时赶上圣诞节，一直等到今年的1月9日才回复。1月19日投回之后，二审等了4周，2月19日意见回来，大修的审稿人同意接收，但编辑又找了第三个审稿人，给了小修。编辑在信中说修回去会直接接收不会再外审。用了2天修回，没想到又送了外审，等了两周今天终于接收了。其实文章本身没怎么改，第二个审稿人的大修难度也不大，审稿也比较快，但在编辑那算起来多耽误了一个多月的时间。不管怎样，文章接收了，感谢编辑和审稿人的肯定。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdb65414148, createdName=ms9921507639737342, createdTime=Mon Mar 06 23:45:32 CST 2017, time=2017-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=830407, encodeId=948283040efb, content=审稿速度:1.0 经验分享：从投稿开始到接受总共26天，其中还包括投稿后返修的1个星期，审稿速度很快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04015414150, createdName=ms9574107592528786, createdTime=Sat Apr 25 08:27:21 CST 2015, time=2015-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=829891, encodeId=dad78298913f, content=审稿速度:2.0 经验分享：只能好历经接近一年终于接收了，中间出现了n个审稿人， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a645414058, createdName=ms2534931155419844, createdTime=Thu Oct 09 02:17:07 CST 2014, time=2014-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=824408, encodeId=5332824408d4, content=计算机模拟方面的期刊，药效团、分子对接、分子动力学模拟方面的文章都收，似乎计算化学类的都可以试试。 本人在这个期刊的投稿经历很痛苦。 第一次投稿，1个月后告知拒稿，理由我很信服，因为是做的同源建模，蛋白的模板以不是最新的同源性高的模板，而且审稿人还提出了其他的一些问题。看到了不足，继续改。想再投一遍试试。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Mon Mar 11 16:59:00 CST 2013, time=2013-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=823645, encodeId=fc7e82364594, content=但愿有好消息呀，已经大修一次了，第二次有个审稿人要拒掉，不知道是凶是吉。 有结果会写下来。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ac05413990, createdName=ms1582630781068122, createdTime=Sun Jan 20 00:05:00 CST 2013, time=2013-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=822980, encodeId=7f84822980b6, content=已经投稿，希望有好的结果~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69165414090, createdName=ms5297671486900813, createdTime=Tue Dec 11 11:37:00 CST 2012, time=2012-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485956, encodeId=36e348595648, content=郁闷！4个月个还处在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Dec 19 21:37:00 CST 2011, time=2011-12-19, status=1, ipAttribution=)]

2013-03-11 ms2466276523160074

计算机模拟方面的期刊，药效团、分子对接、分子动力学模拟方面的文章都收，似乎计算化学类的都可以试试。
本人在这个期刊的投稿经历很痛苦。
第一次投稿，1个月后告知拒稿，理由我很信服，因为是做的同源建模，蛋白的模板以不是最新的同源性高的模板，而且审稿人还提出了其他的一些问题。看到了不足，继续改。想再投一遍试试。

118 0

[GetPortalCommentsPageByObjectIdResponse(id=1093703, encodeId=43c01093e0399, content=选刊时选择几个比较合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093704, encodeId=56921093e0453, content=如何评估自身文章的IF，或者说如何更好地定位自己的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835765, encodeId=7da0835e65ea, content=一审很快，去年12月8号投的，23号接到一审，一个审稿人同意接收，另外一个审稿人大修。期间经历一些波折，编辑没有附上大修的审稿人的审稿意见。发邮件询问时赶上圣诞节，一直等到今年的1月9日才回复。1月19日投回之后，二审等了4周，2月19日意见回来，大修的审稿人同意接收，但编辑又找了第三个审稿人，给了小修。编辑在信中说修回去会直接接收不会再外审。用了2天修回，没想到又送了外审，等了两周今天终于接收了。其实文章本身没怎么改，第二个审稿人的大修难度也不大，审稿也比较快，但在编辑那算起来多耽误了一个多月的时间。不管怎样，文章接收了，感谢编辑和审稿人的肯定。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdb65414148, createdName=ms9921507639737342, createdTime=Mon Mar 06 23:45:32 CST 2017, time=2017-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=830407, encodeId=948283040efb, content=审稿速度:1.0 经验分享：从投稿开始到接受总共26天，其中还包括投稿后返修的1个星期，审稿速度很快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04015414150, createdName=ms9574107592528786, createdTime=Sat Apr 25 08:27:21 CST 2015, time=2015-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=829891, encodeId=dad78298913f, content=审稿速度:2.0 经验分享：只能好历经接近一年终于接收了，中间出现了n个审稿人， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a645414058, createdName=ms2534931155419844, createdTime=Thu Oct 09 02:17:07 CST 2014, time=2014-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=824408, encodeId=5332824408d4, content=计算机模拟方面的期刊，药效团、分子对接、分子动力学模拟方面的文章都收，似乎计算化学类的都可以试试。 本人在这个期刊的投稿经历很痛苦。 第一次投稿，1个月后告知拒稿，理由我很信服，因为是做的同源建模，蛋白的模板以不是最新的同源性高的模板，而且审稿人还提出了其他的一些问题。看到了不足，继续改。想再投一遍试试。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Mon Mar 11 16:59:00 CST 2013, time=2013-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=823645, encodeId=fc7e82364594, content=但愿有好消息呀，已经大修一次了，第二次有个审稿人要拒掉，不知道是凶是吉。 有结果会写下来。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ac05413990, createdName=ms1582630781068122, createdTime=Sun Jan 20 00:05:00 CST 2013, time=2013-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=822980, encodeId=7f84822980b6, content=已经投稿，希望有好的结果~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69165414090, createdName=ms5297671486900813, createdTime=Tue Dec 11 11:37:00 CST 2012, time=2012-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485956, encodeId=36e348595648, content=郁闷！4个月个还处在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Dec 19 21:37:00 CST 2011, time=2011-12-19, status=1, ipAttribution=)]

2013-01-20 ms1582630781068122

但愿有好消息呀，已经大修一次了，第二次有个审稿人要拒掉，不知道是凶是吉。
有结果会写下来。

103 0

[GetPortalCommentsPageByObjectIdResponse(id=1093703, encodeId=43c01093e0399, content=选刊时选择几个比较合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093704, encodeId=56921093e0453, content=如何评估自身文章的IF，或者说如何更好地定位自己的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835765, encodeId=7da0835e65ea, content=一审很快，去年12月8号投的，23号接到一审，一个审稿人同意接收，另外一个审稿人大修。期间经历一些波折，编辑没有附上大修的审稿人的审稿意见。发邮件询问时赶上圣诞节，一直等到今年的1月9日才回复。1月19日投回之后，二审等了4周，2月19日意见回来，大修的审稿人同意接收，但编辑又找了第三个审稿人，给了小修。编辑在信中说修回去会直接接收不会再外审。用了2天修回，没想到又送了外审，等了两周今天终于接收了。其实文章本身没怎么改，第二个审稿人的大修难度也不大，审稿也比较快，但在编辑那算起来多耽误了一个多月的时间。不管怎样，文章接收了，感谢编辑和审稿人的肯定。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdb65414148, createdName=ms9921507639737342, createdTime=Mon Mar 06 23:45:32 CST 2017, time=2017-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=830407, encodeId=948283040efb, content=审稿速度:1.0 经验分享：从投稿开始到接受总共26天，其中还包括投稿后返修的1个星期，审稿速度很快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04015414150, createdName=ms9574107592528786, createdTime=Sat Apr 25 08:27:21 CST 2015, time=2015-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=829891, encodeId=dad78298913f, content=审稿速度:2.0 经验分享：只能好历经接近一年终于接收了，中间出现了n个审稿人， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a645414058, createdName=ms2534931155419844, createdTime=Thu Oct 09 02:17:07 CST 2014, time=2014-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=824408, encodeId=5332824408d4, content=计算机模拟方面的期刊，药效团、分子对接、分子动力学模拟方面的文章都收，似乎计算化学类的都可以试试。 本人在这个期刊的投稿经历很痛苦。 第一次投稿，1个月后告知拒稿，理由我很信服，因为是做的同源建模，蛋白的模板以不是最新的同源性高的模板，而且审稿人还提出了其他的一些问题。看到了不足，继续改。想再投一遍试试。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Mon Mar 11 16:59:00 CST 2013, time=2013-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=823645, encodeId=fc7e82364594, content=但愿有好消息呀，已经大修一次了，第二次有个审稿人要拒掉，不知道是凶是吉。 有结果会写下来。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ac05413990, createdName=ms1582630781068122, createdTime=Sun Jan 20 00:05:00 CST 2013, time=2013-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=822980, encodeId=7f84822980b6, content=已经投稿，希望有好的结果~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69165414090, createdName=ms5297671486900813, createdTime=Tue Dec 11 11:37:00 CST 2012, time=2012-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485956, encodeId=36e348595648, content=郁闷！4个月个还处在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Dec 19 21:37:00 CST 2011, time=2011-12-19, status=1, ipAttribution=)]

2012-12-11 ms5297671486900813

已经投稿，希望有好的结果~

110 0

[GetPortalCommentsPageByObjectIdResponse(id=1093703, encodeId=43c01093e0399, content=选刊时选择几个比较合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093704, encodeId=56921093e0453, content=如何评估自身文章的IF，或者说如何更好地定位自己的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835765, encodeId=7da0835e65ea, content=一审很快，去年12月8号投的，23号接到一审，一个审稿人同意接收，另外一个审稿人大修。期间经历一些波折，编辑没有附上大修的审稿人的审稿意见。发邮件询问时赶上圣诞节，一直等到今年的1月9日才回复。1月19日投回之后，二审等了4周，2月19日意见回来，大修的审稿人同意接收，但编辑又找了第三个审稿人，给了小修。编辑在信中说修回去会直接接收不会再外审。用了2天修回，没想到又送了外审，等了两周今天终于接收了。其实文章本身没怎么改，第二个审稿人的大修难度也不大，审稿也比较快，但在编辑那算起来多耽误了一个多月的时间。不管怎样，文章接收了，感谢编辑和审稿人的肯定。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdb65414148, createdName=ms9921507639737342, createdTime=Mon Mar 06 23:45:32 CST 2017, time=2017-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=830407, encodeId=948283040efb, content=审稿速度:1.0 经验分享：从投稿开始到接受总共26天，其中还包括投稿后返修的1个星期，审稿速度很快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04015414150, createdName=ms9574107592528786, createdTime=Sat Apr 25 08:27:21 CST 2015, time=2015-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=829891, encodeId=dad78298913f, content=审稿速度:2.0 经验分享：只能好历经接近一年终于接收了，中间出现了n个审稿人， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a645414058, createdName=ms2534931155419844, createdTime=Thu Oct 09 02:17:07 CST 2014, time=2014-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=824408, encodeId=5332824408d4, content=计算机模拟方面的期刊，药效团、分子对接、分子动力学模拟方面的文章都收，似乎计算化学类的都可以试试。 本人在这个期刊的投稿经历很痛苦。 第一次投稿，1个月后告知拒稿，理由我很信服，因为是做的同源建模，蛋白的模板以不是最新的同源性高的模板，而且审稿人还提出了其他的一些问题。看到了不足，继续改。想再投一遍试试。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Mon Mar 11 16:59:00 CST 2013, time=2013-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=823645, encodeId=fc7e82364594, content=但愿有好消息呀，已经大修一次了，第二次有个审稿人要拒掉，不知道是凶是吉。 有结果会写下来。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ac05413990, createdName=ms1582630781068122, createdTime=Sun Jan 20 00:05:00 CST 2013, time=2013-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=822980, encodeId=7f84822980b6, content=已经投稿，希望有好的结果~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69165414090, createdName=ms5297671486900813, createdTime=Tue Dec 11 11:37:00 CST 2012, time=2012-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485956, encodeId=36e348595648, content=郁闷！4个月个还处在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Dec 19 21:37:00 CST 2011, time=2011-12-19, status=1, ipAttribution=)]

2011-12-19 匿名用户

郁闷！4个月个还处在under review

412 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务